
FDA Authorizes Monoclonal Antibodies for Treatment of COVID-19
WASHINGTON, D.C. — The U.S. Food and Drug Administration has issued an emergency use authorization (EUA) for casirivimab and imdevimab to be administered together for the treatment of mild to moderate …
Read More